Hagenbuchner J
From Bioblast
Revision as of 16:55, 13 November 2013 by Krumschnabel Gerhard (talk | contribs)
The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.
| Name | Hagenbuchner Judith, |
|---|---|
| Institution | |
| Address | Tyrolean Cancer Research Institute
Department of Pediatrics IV Innsbruck, Austria, |
| City | |
| State/Province | |
| Country | |
| Weblink | |
| O2k-Network Lab |
Labels:
Publications
| Published | Reference | |
|---|---|---|
| Kuznetsov 2022 Antioxidants (Basel) | 2022 | Kuznetsov AV, Margreiter R, Ausserlechner MJ, Hagenbuchner J (2022) The complex interplay between mitochondria, ROS and entire cellular metabolism. Antioxidants (Basel) 11:1995. doi: 10.3390/antiox11101995 |
| Kuznetsov 2020 Cells | 2020 | Kuznetsov AV, Javadov S, Grimm M, Margreiter R, Ausserlechner MJ, Hagenbuchner J (2020) Crosstalk between mitochondria and cytoskeleton in cardiac cells. Cells 9:E222. |
| Hagenbuchner 2013 Oncogene | 2013 | Hagenbuchner J, Kuznetsov AV, Obexer P, Ausserlechner MJ (2013) BIRC5/Survivin enhances aerobic glycolysis and drug resistance by altered regulation of the mitochondrial fusion/fission machinery. Oncogene 32:4748-57. |
| Hagenbuchner 2012 J Cell Sci | 2012 | Hagenbuchner J, Kuznetsov AV, Hermann M, Hausott B, Obexer P, Ausserlechner MJ (2012) FOXO3-induced reactive oxygen species are regulated by BCL2L11 (Bim) and SESN3. J Cell Sci 125:1191-1203. |
